Results 271 to 280 of about 108,384 (342)

Remodeling the Tumor Immune Environment in Breast Cancer via Bortezomib-based Combination Therapy. [PDF]

Int J Biol Sci
Huang S, Chen Q.
europepmc   +1 more source

Inhibition by chloroquine of the class II major histocompatibility complex-restricted presentation of endogenous antigens varies according to the cellular origin of the antigen-presenting cells, the nature of the T-cell epitope, and the responding T cell.

, 1993
S Lombard-Platlet, Patrick Bertolino, Hongkui Deng, Denis Gerlier, C. Rabourdin-Combe   +4 more
openalex   +1 more source

Induction of major histocompatibility class II antigen on microglial cells in postnatal and adult rats following intraperitoneal injections of lipopolysaccharide

, 1997
Yee‐Kong Ng, Eng‐Ang Ling
openalex   +2 more sources

Are we hallucinating or can psychedelic drugs modulate the immune system to control inflammation?

British Journal of Pharmacology, EarlyView.
Psychedelic drugs that activate 5‐HT2A receptors have been long used for cultural, medicinal and recreational purposes. Interest in psychedelics for treating psychiatric disorders has resurged recently and is well documented; less well recognised are their anti‐inflammatory properties. Growing evidence now demonstrates that psychedelics modulate immune
Omar Qureshi, Jamie Cowley, Ashley Pegg, Alison J. Cooper, John Gordon, Catherine A. Brady, Antonio Belli, Sam Butterworth, Rachel Upthegrove, Nick Andrews, Nicholas M. Barnes   +10 more
wiley   +1 more source

How the Cigarette Fire Burns the Rheumatoid Joints. [PDF]

JMA J
Tang IYK, Mok CC.
europepmc   +1 more source

A Combinatorial Effect of Immune Checkpoint Inhibitors and CD40 Agonistic Antibody in Murine Pancreatic Cancer Model

Cancer Science, EarlyView.
We established and extensively analyzed an organoid‐based mouse model that closely mimics human pancreatic ductal adenocarcinoma. Monotherapy with an immune checkpoint inhibitor cocktail or a CD40 agonist antibody showed minimal efficacy. However, combining both reagents produced a strong synergistic effect by enhancing anti‐tumor immunity.
Juri Ichikawa, Hiroshi Okuda, Kuniyuki Kawano, Shingo Kato, Shinya Sato, Ryo Kuroishikawa, Daisuke Kurotaki, Wataru Kawase, Haruka Yoshida, Yukihiko Hiroshima, Itaru Endo, Shin Maeda, Tomohiko Tamura   +12 more
wiley   +1 more source

CAR T cell therapy in type 1 diabetes: what we know and what remains to be explored. [PDF]

Biol Proced Online
Pattanaik SK, Rath D, Moeini AM, Nabi Afjadi M.   +3 more
europepmc   +1 more source

Major histocompatibility complex class II antigen expression during potentiation of line-10 tumor immunity after intralesional administration of bacillus Calmette-Guérin

, 1990
Peter A. Steerenberg, Wim H. de Jong, E. Geerse, B. J. Aleva, C. M. L. T. Besselink, B.T.T.M. van Rens, Victor P. M. G. Rutten, Lambert G. Poels, Rik J. Scheper, Willem Den Otter, E. J. Ruitenberg   +10 more
openalex   +2 more sources

Tumor Microenvironments in Malignant Ovarian Germ Cell Tumors: MHC Class I Loss and T‐Cell Exhaustion in Dysgerminoma

Cancer Science, EarlyView.
Malignant ovarian germ cell tumor subtypes exhibit distinct tumor microenvironments. Dysgerminomas harbor abundant nonexhausted T cells, with progenitor exhausted T cells present in 60% of PD‐1–positive cases. However, MHC class I expression is lost across all analyzed subtypes, suggesting that restoring class I expression in dysgerminomas may enhance ...
Miya Nakashima, Takeshi Iwasaki, Yoshihiro Katayama, Masatoshi Shimo, Ken Takigawa, Naomi Shimada, Michiko Matsushita, Satoshi Kuwamoto, Shinya Sato, Masato Toya, Kohta Miyawaki, Koichi Akashi, Kiyoko Kato, Yoshinao Oda   +13 more
wiley   +1 more source

Shaping the Immune Response: Cathepsins in Virus-Dendritic Cell Interactions. [PDF]

Cells
Niedzielska A, Bossowska-Nowicka M, Biernacka Z, Gregorczyk-Zboroch K, Toka FN, Szulc-Dąbrowska L.   +5 more
europepmc   +1 more source